
Collaboration - July 2, 2014
Cobra Biologics and QuiaPEG collaborate
Contract Manufacturing Organisation Cobra Biologics and biotech company QuiaPEG Pharmaceuticals AB have announced a strategic alliance. The collaboration will be focused on the processing of biological drugs to increase half-life and reduce production costs by using a new PEGylation technology platform. PEGylation is the modification of a protein, peptide or non-peptide molecule by linking polyethylene glycol (PEG) […]